Irish Drug Maker Shire Agrees to Buy Dyax in Deal Worth Up to $6.5 Billion
The transaction would be the latest in an acquisition spree by Shire since its tentative agreement to be bought by the drug maker AbbVie was terminated.
last time seen on http://rss.nytimes.com/c/34625/f/640316/s/4b2afe35/sc/21/l/0L0Snytimes0N0C20A150C110C0A30Cbusiness0Cdealbook0Cshire0Edyax0Ecorp0Edeal0Bhtml0Dpartner0Frss0Gemc0Frss/story01.htm
No comments:
Post a Comment